drugset / Trial / NCT01999270
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
NaSingle-groupOpen-labelTreatment
Summary
To determine if FDOPA-PET/MRI imaging can predict response to treatment of bevacizumab.
Timeline
- Start
- 2013-04
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | — | Intravenous |
| Background | Irinotecan | Small molecule | — | Intravenous |